** UBS starts Germany's Jenoptik JENGn.DE with "buy",
saying the optical electronics group is a tech leader in
photonics with underappreciated potential in the long term
** Jenoptik's stock has declined 25% this year due to the
postponement of 2025 targets by one year when key customer ASML
ASML.AS in October reduced its 2025 guidance
** Even taking a conservative view and assuming a
temporarily weaker 2025, and 2026 a touch below guidance, UBS
still sees attractive upside potential on a 12-month view
** In broker's opinion, 2025 will be a transition year, but
the 2026 guidance is achievable
** UBS believes Jenoptik's increased optics capacity and the
growth in non-EUV units should help Jenoptik reach its 2026
target
** The brokerage expects the focus of the company to remain
on its core portfolio (semis, electronics and medtech
businesses) in the future
** Shares in Jenoptik are up 5%, topping the German mid-cap
index .MDAXI
(Reporting by Amir Orusov)
((Amir.orusov@thomsonreuters.com))